Rizky Indrameikha Sugianto1, Karen Ostendorf1, Nima Memaran1, Anette Melk2,3, Elena Bauer1, Jeannine von der Born1, Jun Oh4, Markus J Kemper5, Rainer Buescher6, Bernhard M W Schmidt7. 1. Department of Pediatric Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. 2. Department of Pediatric Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Melk.Anette@mh-hannover.de. 3. Children's Hospital, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Melk.Anette@mh-hannover.de. 4. University Children's Hospital, University Medical Center-Hamburg-Eppendorf, Hamburg, Germany. 5. Department of Pediatrics and Adolescent Medicine, Asklepios Hospital Nord-Heidberg, Hamburg, Germany. 6. University Children's Hospital, Essen University Hospital, Essen, Germany. 7. Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Abstract
BACKGROUND: Pulse wave velocity (PWV) is a measure of arterial stiffness. We investigated PWV and blood pressure (BP) to determine to what extent BP changes contribute to arterial stiffness, and secondly, to identify influencing factors on BP in children after kidney transplantation. METHODS: Seventy children ≥ 2.5 years post-transplantation with at least two PWV measurements were included. Changes of systolic (Δ SBP) and diastolic BP (Δ DBP) were classified into "stable/decreasing," "1-10 mmHg increase," and " > 10 mmHg increase." Linear mixed modeling for PWV z-score (PWVz) adjusted either for Δ SBP or Δ DBP was performed. An extended dataset with monthly entries of BP, immunosuppression, and creatinine was obtained in 35 participants over a median of 74 months to perform linear mixed modeling for SBP and DBP. RESULTS: PWVz increased with a rate of 0.11/year (95% CI 0.054 to 0.16). Compared to participants with stable BP, those with 1-10-mmHg SBP and DBP increase showed a higher PWVz of 0.59 (95% CI 0.046 to 1.13) and 0.86 (95% CI 0.43 to 1.30), respectively. A > 10-mmHg BP increase was associated with an even higher PWVz (SBP β = 0.78, 95% CI 0.22 to 1.34; DBP β = 1.37, 95% CI 0.80 to 1.94). Female sex and participants with lower eGFR showed higher PWVz. In the extended analysis, DBP was positively associated with cyclosporin A and everolimus trough levels. CONCLUSIONS: A higher increase of PWV is seen in patients with greater BP increase, with higher cyclosporin A and everolimus trough levels associated with higher BP. This emphasizes the role of BP as a modifiable risk factor for the improvement of cardiovascular outcome after transplantation. A higher resolution version of the Graphical abstract is available as Supplementary information.
BACKGROUND: Pulse wave velocity (PWV) is a measure of arterial stiffness. We investigated PWV and blood pressure (BP) to determine to what extent BP changes contribute to arterial stiffness, and secondly, to identify influencing factors on BP in children after kidney transplantation. METHODS: Seventy children ≥ 2.5 years post-transplantation with at least two PWV measurements were included. Changes of systolic (Δ SBP) and diastolic BP (Δ DBP) were classified into "stable/decreasing," "1-10 mmHg increase," and " > 10 mmHg increase." Linear mixed modeling for PWV z-score (PWVz) adjusted either for Δ SBP or Δ DBP was performed. An extended dataset with monthly entries of BP, immunosuppression, and creatinine was obtained in 35 participants over a median of 74 months to perform linear mixed modeling for SBP and DBP. RESULTS: PWVz increased with a rate of 0.11/year (95% CI 0.054 to 0.16). Compared to participants with stable BP, those with 1-10-mmHg SBP and DBP increase showed a higher PWVz of 0.59 (95% CI 0.046 to 1.13) and 0.86 (95% CI 0.43 to 1.30), respectively. A > 10-mmHg BP increase was associated with an even higher PWVz (SBP β = 0.78, 95% CI 0.22 to 1.34; DBP β = 1.37, 95% CI 0.80 to 1.94). Female sex and participants with lower eGFR showed higher PWVz. In the extended analysis, DBP was positively associated with cyclosporin A and everolimus trough levels. CONCLUSIONS: A higher increase of PWV is seen in patients with greater BP increase, with higher cyclosporin A and everolimus trough levels associated with higher BP. This emphasizes the role of BP as a modifiable risk factor for the improvement of cardiovascular outcome after transplantation. A higher resolution version of the Graphical abstract is available as Supplementary information.
Authors: Daniela Kracht; Rukshana Shroff; Sabrina Baig; Anke Doyon; Christoph Jacobi; Rene Zeller; Uwe Querfeld; Franz Schaefer; Elke Wühl; Bernhard M W Schmidt; Anette Melk Journal: Am J Hypertens Date: 2011-08-25 Impact factor: 2.689
Authors: Anna Francis; David W Johnson; Anette Melk; Bethany J Foster; Katrina Blazek; Jonathan C Craig; Germaine Wong Journal: Clin J Am Soc Nephrol Date: 2020-02-19 Impact factor: 8.237
Authors: João Pedro Ferreira; Nicolas Girerd; Bruno Pannier; Patrick Rossignol; Gerard M London Journal: Am J Nephrol Date: 2016-11-30 Impact factor: 3.754
Authors: Daniela Thurn; Anke Doyon; Betul Sözeri; Aysun K Bayazit; Nur Canpolat; Ali Duzova; Uwe Querfeld; Bernhard M W Schmidt; Franz Schaefer; Elke Wühl; Anette Melk Journal: Am J Hypertens Date: 2015-05-05 Impact factor: 2.689
Authors: Adrian Covic; Nicoleta Mardare; Paul Gusbeth-Tatomir; Octavian Prisada; Radu Sascau; David J A Goldsmith Journal: Nephrol Dial Transplant Date: 2006-07-19 Impact factor: 5.992
Authors: Eva Kis; Orsolya Cseprekál; Zsófia Horváth; Gábor Katona; Bertalan C Fekete; Erzsébet Hrapka; András Szabó; Attila J Szabó; Andrea Fekete; György S Reusz Journal: Pediatr Res Date: 2008-01 Impact factor: 3.756
Authors: Elaine M Urbina; Richard V Williams; Bruce S Alpert; Ronnie T Collins; Stephen R Daniels; Laura Hayman; Marc Jacobson; Larry Mahoney; Michele Mietus-Snyder; Albert Rocchini; Julia Steinberger; Brian McCrindle Journal: Hypertension Date: 2009-09-03 Impact factor: 10.190